This article is more than 5 years old. Information may no longer be current.

Integra LifeSciences to create new publicly traded spine company

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Integra LifeSciences recently announced plans to spin off its spine business to Integra shareholders on a tax-free basis.

The proposed plan will result in a new, independent, publicly traded company called SeaSpine, with an estimated $140 million of trailing 12-month revenue as of Sept. 30, 2014. The company will focus on the development, marketing and selling of a comprehensive portfolio of spine hardware and orthobiologics products, according to a company press release.

Integra plans to remain focused on providing specialty surgical solutions, orthopedics and tissue technologies to surgeons, according to the release. As part of a larger transformation strategy that began in 2012, Integra’s portfolio realignment is centered on optimizing business and accelerating growth.

SeaSpine will operate out of locations in Southern California, and Integra’s board of directors plans to name Kirt Stephenson, former CEO and co-founder of SeaSpine, as chairman of the board of directors of the new SeaSpine, according to the release.

The company anticipates completion of the transaction within 12 months.

Reference: www.integralife.com